Sino Biopharmaceutical Limited
This article relies largely or entirely on a single source. (January 2020) |
Company type | listed | ||||||
---|---|---|---|---|---|---|---|
| |||||||
Industry | Pharmaceutical | ||||||
Founded | 2000 | ||||||
Headquarters | , | ||||||
Area served | People's Republic of China | ||||||
Key people | Chairwoman of the Board: Ms. Tse, Theresa Y Y CEO: Mr. Tse, Eric S Y[1][2] | ||||||
Parent | Charoen Pokphand Group[citation needed] | ||||||
Chinese name | |||||||
Simplified Chinese | |||||||
Traditional Chinese | |||||||
| |||||||
Chinese short name | |||||||
Simplified Chinese | |||||||
Traditional Chinese | |||||||
| |||||||
second alternative short name | |||||||
Simplified Chinese | |||||||
Traditional Chinese | |||||||
| |||||||
Website | Sino Biopharmaceutical Limited |
Sino Biopharmaceutical Limited (SEHK: 1177|Hang Seng Index component) (simplified Chinese:
Being a member of Charoen Pokphand Group[citation needed] and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.[3]
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products.[4]
References
[edit]- ^
"Sino Biopharmaceutical Limited: Profile". Retrieved 2024-07-29.
Ms. Y. Y. Tse - Exec. Chairman... Mr. Eric S. Y. Tse - CEO & Exec. Director
- ^ "Sino Biopharmaceutical Limited 1177.HK: Leadership". Reuters. Retrieved 2024-07-29.
Y. Y. Tse - Executive Chairwoman of the Board, S. Y. Tse - Chief Executive Officer, Executive Director
- ^ "Sino Biopharmaceutical | Company Overview & News". Forbes. Archived from the original on 2023-05-23.
- ^ About the company
External links
[edit]- Business data for Sino Biopharmaceutical Limited:
- Sino Biopharmaceutical Limited